4-Fluoro-2-(4-fluorophenyl)-N-methyl-5-(2-methyl-5-((1-pyrimidin-2-ylcyclopropyl)carbamoyl)phenyl)benzofuran-3-carboxamide
BMS-929075 is under investigation in clinical trial NCT01525212 (Multiple Ascending Dose Study of BMS-929075 in Hepatitis C Virus (HCV) Infected Patients).